Medtronic Launches Exchange Offer to Divest 80% Stake in MiniMed
MMED has more than doubled off its 52-week low of $10.65.
Summary
Medtronic filed an S-4 to launch an exchange offer divesting up to 80.1% of its MiniMed stake. The offer expires October 9, 2026, and would leave Medtronic with approximately 9.76% ownership if fully subscribed.
Key Events · M&A and Partnerships · MMED
-
Exchange Offer Launched
Medtronic is offering to exchange up to 225,361,295 newly issued MiniMed shares for outstanding Medtronic ordinary shares, representing approximately 80.1% of MiniMed's total outstanding shares.
-
Exchange Ratio Terms
The exchange ratio values Medtronic shares at 100% of Average MDT Price and MiniMed shares at 93% of Average MMED Price, with an upper limit of 4.5939 MiniMed shares per Medtronic share. The indicative ratio as of September 11, 2026 was 4.3599.
-
Ownership Transformation
If fully subscribed, Medtronic's ownership of MiniMed would fall from 89.86% to approximately 9.76%. If oversubscribed, Medtronic may exchange its entire remaining interest, making MiniMed fully independent.
-
Timeline and Conditions
The Exchange Offer expires October 9, 2026. Completion requires at least 112,680,647 MiniMed shares to be issued and receipt of a tax opinion from Skadden confirming Section 355 tax-free treatment.
Analysis · MMED · Industrial Applications And Services
Medtronic is offering to exchange up to 225.4 million newly issued MiniMed shares for its own ordinary shares, a transaction that would reduce Medtronic's ownership of MiniMed from 89.86% to approximately 9.76% (or potentially zero if oversubscribed). The exchange ratio values MiniMed at a 7% discount to its three-day VWAP, with an upper limit of 4.5939 MiniMed shares per Medtronic share. This is a transformative corporate event that will dramatically increase MiniMed's public float and establish its independence from Medtronic. The filing also discloses Medtronic expects to recognize a pre-tax gain of approximately $1.7 billion on the transaction.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 41.1% of the 372 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MMED was trading at $22.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.3B. The 52-week trading range was $10.65 to $24.43. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.